Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 443,061 |
|
|||||
| News | - | ||||||
| Day High | 4.465 | Low High |
|||||
| Day Low | 4.22 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Abeona Therapeutics Inc | ABEO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.17 | 4.04% | 4.38 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.22 | 4.22 | 4.465 | 4.38 | 4.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,833 | 443,061 | $ 4.36 | $ 1,929,677 | - | 2.83 - 9.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:50:17 | 3 | $ 4.47 | USD |
Abeona Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 108.75M | 24.77M | - | 4.57M | -54.19M | -2.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Abeona Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABEO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.17 | 4.465 | 4.01 | 4.13 | 529,878 | 0.21 | 5.04% |
| 1 Month | 4.35 | 5.11 | 4.01 | 4.45 | 827,716 | 0.03 | 0.69% |
| 3 Months | 8.39 | 8.87 | 3.05 | 4.88 | 731,797 | -4.01 | -47.79% |
| 6 Months | 4.97 | 9.01 | 3.05 | 5.21 | 498,577 | -0.59 | -11.87% |
| 1 Year | 3.08 | 9.01 | 2.83 | 4.95 | 327,768 | 1.30 | 42.21% |
| 3 Years | 1.67 | 9.01 | 0.1303 | 1.39 | 869,397 | 2.71 | 162.28% |
| 5 Years | 5.64 | 9.01 | 0.1303 | 1.96 | 1,221,837 | -1.26 | -22.34% |
Abeona Therapeutics Description
| Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. |
